In the following section, we will provide a detailed discussion of recent advances in our understanding of purinergic signaling during seizures and epilepsy, including the release and degradation of purines and the contribution of the different purinergic receptor subtypes to disease pathology. This evidence concerns the gene P2RY1 and epilepsy.